Following promising research results, retatrutide, a new peptide therapy for managing adult-onset diabetes , has obtained regulatory approval from the Healthcare and Healthcare Agency ( MHRA body). Initial availability is currently expected via specialist weight management clinics and particular National Health Service organisations in coming timef